CTS (Therapeutic Devices) Overview
Latest Deal Type
Out of Business
CTS (Therapeutic Devices) General Information
Description
Developer of a molecular imaging platform designed to detect cancer. The company's platform develops clinical products for cancer imaging and therapeutics and its core proprietary technology is based on gene which are specifically triggered inside cancer cells which are based on cell-specific gene promoters, enabling patients to detect early-stage cancer and start treatment according to it and also can be freeze-dried for long-term storage without losing efficacy and rapidly reconstituted for easy administration.
Want to dig into this profile?
We’ll help you find what you need
Learn more
CTS (Therapeutic Devices) Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 3. Out of Business |
01-Apr-2019 |
|
00.00 |
|
Completed |
Out of Business |
| 2. Later Stage VC |
17-Sep-2014 |
00.00 |
00.00 |
|
Completed |
Generating Revenue |
| 1. Accelerator/Incubator |
|
|
|
|
Completed |
Startup |